To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05830084
Title Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma (REGO-EWING)
Acronym REGO-EWING
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | child
Covered Countries NLD | ITA | FRA | ESP | DNK | AUS

Facility Status City State Zip Country Details
Perth Children's Hospital RECRUITING Perth WA6009 Australia Details
Rigshospitalet NOT_YET_RECRUITING Copenhagen DK-2100 Denmark Details
Gustave Roussy RECRUITING Villejuif Ile De France 94805 France Details
Istituto Nazionale dei Tumori NOT_YET_RECRUITING Milan 20133 Italy Details
Princess Máxima Center RECRUITING Utrecht 113 Netherlands Details
Vall d'Hebron University Hospital NOT_YET_RECRUITING Barcelona 119-12 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field